Skip to content

Nomination Committee

At the Annual General Meeting of LIDDS AB (publ) May 17, 2021 it was resolved that a Nomination Committee shall be appointed and consist of three members, appointed by the two largest shareholders by September 30, 2021 together with the Chairman of Board of Directors of LIDDS.

The following committee is appointed for the Annual General Meeting 2022:

  • Bengt-Åke Bengtsson, Chairman
  • Olle Isaksson
  • Bengt Viterius
  • Jan Törnell (Chairman of LIDDS)

Shareholders who wish to contact the Nomination Committee can do so at the following e-mail address: info@liddspharma.com.